Page 26 - Aneeka Chatterjee

Som Distilleries to invest at least Rs 1,000 crore in three years: CMD

Arora talks about the market trends and robust growth trajectory

Management education is a key area for a developing country: XIME chairman

Prof J Philip, founder and chairman of Xavier Institute of Management & Entrepreneurship (XIME), talks about the evolution of management education in India and the trends in the sector

Biocon Q4 results: Net profit falls 57% to Rs 136 crore; revenue up 0.94%

Biocon has re-appointed Kiran Mazumdar Shaw as an Executive Director of the company for a further period of 5 years starting April 2025

Infosys Prize gets age limit, now only for researchers up to 40 yrs old

The existing prize categories will remain largely unchanged, except for Economics, which will now be a separate category instead of being under Social Sciences

HCG expands with two new state-of-the-art cancer care centres in Bengaluru

HCG's network presently encompasses 21 comprehensive cancer centres with 24 hospitals across India and Africa, and seven daycare centres

Hospital players enhance focus on cancer care amid a surge in cases

By 2025, cancer cases projected to hit 1.57 million, up 13% from 2020

Prestige Estates' CEO Venkata Narayana K resigns, firm outlines roadmap

Venkata Narayana K became CEO of Prestige Estates in August 2017, following his tenure as chief financial officer and company secretary

GCCs drove India office demand with 37% share in leasing activity in Q1

India's prime office markets saw a 4-8 per cent year-on-year rise in rentals in the first quarter, propelled by strong demand and an influx of high-quality supply, according to Colliers' latest report

Breweries ramp up production on record sales forecast this summer

The companies ramp up production, diversify offerings on record summer sales forecast

Britannia Industries Q4 results: Net profit down 3.8% at Rs 536.6 crore

The operating margins contracted by 110 basis points to 17.3 per cent during the March quarter from 18.4 per cent in the year-ago period due to price cuts undertaken during the quarter under review

Sanofi India introduces diabetes drug 'Soliqua' at Rs 1,850 per pen

Sanofi reported that in India, over 100 million individuals are grappling with type 2 diabetes and its associated complexities

Realtors retool pricing strategies amid rising cost of construction

The higher costs in Mumbai can be attributed to the increased prices of essential construction materials like cement, reinforced steel, structural steel, and stones

Bharat Biotech co-founder Krishna Ella takes helm as President of IVMA

Ella takes over the presidency from Adar C Poonawalla, who held the post from 2019 to March 2024

What IT sector wants: AI push, clarity on labour laws on LS polls wishlist

Industry leaders highlighted the need to prioritise original research and development in software intellectual property (IP) creation and the simplification of labour laws

Syngene Q4 results: Net profit up 6% to Rs 189 cr, revenue declines 8%

Syngene International shares ended the day's trade on BSE at Rs 694.2 apiece, down one per cent

LS polls: Tumkur hopes yarn will spin again for its textile industry

The sector is facing multiple challenges like labour shortage, falling exports and bureaucratic delays

Lodha Q4 results: Net profit slips 10% to Rs 667 crore, FY24 profit up 300%

Realty firm Macrotech Developers reported its best ever quarterly and annual pre-sales performance with robust margins

Rising disposable income a big opportunity for us: AABL's Tushar Bhandari

Associated Alcohol Breweries Ltd (AABL), one of the leading distilleries in India, is strategically targeting the evolving preferences of new-age consumers

Fortis opens 80-bed tertiary hospital in Bengaluru, invests about Rs 7 cr

Fortis Hospital aims for an Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) growth of about 20 per cent

Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil

Biomm SA develops and commercialises complex biotech and biosimilar drug products